Ascend Laboratories, LLC recalls Amlodipine and Olmesartan Medoxomil Tablets
- Recalling company
- Ascend Laboratories, LLC
- Product
- Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, Rx Only, 30-count bottle, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC., Parsippany, NJ 07054, NDC 67877-501-30.
- Reason
- Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- May 5, 2026
- Reported
- Jun 10, 2026
- Distribution
- U.S.A. Nationwide
- Status
- Ongoing
- Quantity
- 15,696 x 30's bottles
- Lot / codes
- Lot: 24123460, Expires: October 31, 2027.
- Company location
- Bedminster, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0556-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0556-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.